Oxford Gene Technology's CytoSure Haematological Cancer +SNP array is designed for the study of the haematological malignancies chronic lymphocytic leukaemia (CLL) and multiple myeloma (MM), as well as myeloproliferative neoplasms (MPN) and myelodysplastic syndromes (MDS).
The new array offers confident detection of both copy number variation (CNV)
and loss of heterozygosity (LOH) on a single chip for these diseases. This
is achieved by utilising the company's novel array design, which combines
long oligo array comparative genomic hybridisation (aCGH) probes for CNV
detection with fully validated single nucleotide polymorphism (SNP) content
for identifying LOH.